Enovix Chief Accounting Officer Sells Shares as Analysts Remain Positive
Kristina Truong sold 1,015 Enovix shares for $6,759.90 on June 13, 2026.
Key Points
- Enovix's Chief Accounting Officer Kristina Truong sold 1,015 shares on June 13, 2026, valued at $6,759.90.
- Enovix trades on the NasdaqGS with a market cap of approximately $1.54 billion, and a 52-week range between $4.62 and $16.49.
- Analysts maintain a buy consensus for Enovix with a mean price target of $13.10, highlighting potential growth.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Kristina Truong, the Chief Accounting Officer of Enovix Corporation, sold 1,015 shares of the company on June 13, 2026. The transaction was valued at approximately $6,759.90, with shares sold at an average price of $6.66. This sale was not part of a pre-planned trading program.
Insider Buying and Selling at Enovix Corporation
Several other insiders have been active at Enovix recently. Joseph Ian Malchow, Pegah Ebrahimi, Gregory Reichow, Daniel McCranie, and Betsy Atkins each acquired 29,104 shares on June 11, 2026, without a specified purchase price, indicating significant insider interest in the company.
Other Institutional Activity in Enovix
Among institutional investors, BlackRock, Inc. increased its position by 1,280,739 shares, now holding 15,330,789 shares valued at about $79.4 million. Vanguard Capital Management LLC and Vanguard Portfolio Management LLC both initiated new positions, acquiring 8,379,238 and 8,051,198 shares, respectively. UBS Group AG slightly reduced its stake by 205,274 shares, holding 5,770,071 shares worth around $29.9 million. Geode Capital Management, LLC added 458,598 shares, bringing its total to 4,872,090 shares.
Enovix Corporation Stock Up 110.7%
Shares of NasdaqGS:ENVX were trading near $7.08. Enovix has a market capitalization of about $1.54 billion and shows a forward P/E ratio that is not meaningful due to its lack of profitability. The stock has a beta of 2.215, indicating higher volatility compared to the market. Its 52-week range spans from $4.62 to $16.49, with a 50-day moving average of $6.74 and a 200-day moving average of $7.84.
$ENVX stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Enovix reported revenues of $34.32 million with a revenue growth rate of 49.1%. However, the company is not currently profitable, reflected in a net margin of 0% and a return on equity of -71.3%. Investors are looking forward to the next earnings announcement scheduled for July 29, 2026.
Analysts Set New Price Targets
Analysts have maintained a positive outlook on Enovix. On May 14, 2026, Oppenheimer, Craig-Hallum, and Benchmark reiterated their buy ratings, with price targets of $21, $8, and $15, respectively. TD Cowen maintained a hold rating with a $7 target. Enovix's consensus rating remains a buy, with an average target price of $13.10 based on 10 analyst opinions.
About Enovix Corporation
Enovix Corporation, headquartered in Fremont, California, designs and manufactures advanced lithium-ion battery cells. The company serves a variety of sectors, including wearables, smartphones, and electric vehicles. Founded in 2006, Enovix is led by CEO Dr. Raj Talluri and employs 664 people.
Bottom Line
Kristina Truong's recent sale of Enovix shares is noteworthy, but it comes amid a backdrop of significant insider buying and positive institutional interest. Analysts continue to see potential in Enovix, maintaining a buy consensus with price targets suggesting room for growth. It's important to remember that insider transactions and 13F filings provide historical data and might not reflect current positions.
Get Enovix Corporation alerts
New 13F filings, insider trades, and analyst moves on $ENVX, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.